Tanezumab in Osteoarthritis of the Knee
This study has been completed.
Information provided by:
First received: August 11, 2008
Last updated: January 4, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2009|
|Primary Completion Date:||September 2009 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||December 21, 2010|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Hochberg MC, Tive LA, Abramson SB, Vignon E, Verburg KM, West CR, Smith MD, Hungerford DS. When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program. Arthritis Rheumatol. 2016 Feb;68(2):382-91. doi: 10.1002/art.39492.